Gender difference in antidiuretic response to desmopressin

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 5, 2011, Pages 1116-1122

  Juul, Kristian Vinter ^a   Klein, Bjarke Mirner ^a   Sandström, Rikard ^a   Erichsen, Lars ^a   Nørgaard, Jens Peter ^a  

^a Ferring Pharmaceuticals AS   (Denmark)

Author keywords

Antidiuresis; Arginine vasopressin receptor 2; Hyponatremia; Osmoregulation; X chromosome inactivation

Indexed keywords

DESMOPRESSIN; SODIUM;

ADULT; AGE; AGED; ANTIDIURESIS; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPONATREMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NOCTURIA; PHASE 1 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SEX DIFFERENCE; SODIUM BLOOD LEVEL; URINE VOLUME; WEIGHT;

EID: 79955782300     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00741.2010     Document Type: Article

References (24)

1. Agerso H, Seiding LL, Riis A, Lovgren U, Karlsson MO, Senderovitz T. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. Br J Clin Pharmacol 58: 352-358, 2004.
2. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 83: 1-10, 2008.
3. Anderson GD. Sex, and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health 14: 19-29, 2005.
4. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 229: 131-134, 1991.
5. Baylis PH, Thompson CJ. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol 29: 549-576, 1988.
6. Brøsen K. (Sex differences in pharmacology). Ugeskr Laeger 169: 2408-11, 2007.
7. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434: 400-404, 2005.
8. Graugaard-Jensen C, Hvistendahl GM, Frøkiær J, Bie P, Djurhuus JC. The influence of oral contraceptives on diurnal urine regulation (Abstract). http://www.icsoffice.org/Events/ViewEvent.aspx?EventID=105.
9. Hvistendahl GM, Frøkiær J, Nielsen S, Djurhuus JC. Gender differences in night-time plasma arginine vasopressin, and delayed compensatory urine output in the elderly population after desmopressin. J Urol 178: 2671-2676, 2007.
10. Kelleher H, Henderson S. Severe hyponatremia due to desmopressin. J Emerg Med 30: 45-47, 2006.
11. Liu J, Sharma N, Zheng W, Ji H, Tam H, Wu X, Manigrasso MB, Sandberg K, Verbalis JG. Sex differences in vasopressin V2 receptor expression, and vasopressin-induced antidiuresis. Am J Physiol Renal Physiol 300: F433-F440, 2011.
12. Liu J, Ji H, Zheng W, Verbalis J, Sandberg K. Gonadal hormone regulation of the renal vasopressin V2 receptor (Abstract). FASEB J: 22, Suppl 1: 1159.24. 2008.
13. Migeon B. X inactivation, female mosaicism, and sex differences in renal diseases. J Am Soc Nephrol 19: 2052-2059, 2008.
14. Moon DG, Jin MH, Lee JG, Kim JJ, Kim MG, Cha DR. Antidiuretic hormone in elderly male patients with severe nocturia: a circadian study. BJU Int 94: 571-575, 2004.
15. Ørstavik KH. Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr Suppl 95: 24-29, 2006.
16. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2: 349-351, 2001.
17. Ranchin B, Boury-Jamot M, Blanchard G, Dubourg L, Hadj-Aïssa A, Morin D, Durroux T, Cochat P, Bricca G, Verbavatz JM, Geelen G. Familial nephrogenic syndrome of inappropriate antidiuresis: dissociation between aquaporin-2, and vasopressin excretion. J Clin Endocrinol Metab 95: E37-E43, 2010.
18. Rembratt A, Riis A, Nørgaard JP. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn 25: 105-109, 2006.
19. Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP, Keefe DL. Genome and hormones: gender differences in physiology selected contribution: sex differences in osmotic regulation of AVP and renal sodium handling. J. Appl Physiol 91: 1893-1901, 2001.
20. Stachenfeld NS, Keefe DL. Estrogen effects on osmotic regulation of AVP and fluid balance. Am J Physiol Endocrinol Metab 283: E711-E721, 2002.
21. Stachenfeld NS, Dipietro L, Palter SF, Nadel ER. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol Regul Integr Comp Physiol 274: R187-R195, 1998.
22. Van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, Robertson G, Weiss J; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology in nocturia: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21: 179-183, 2002.
23. Weiss J, Zinner N, Daneshgari F, Klein B, Nørgaard JP, Ancoli-Israel S. Desmopressin orally disintegrating tablet effectively reduces symptoms of nocturia, and prolongs undisturbed sleep in patients with nocturia: results of a randomized placebo-controlled study (Abstract). http://www.icsoffice.org/Events/ViewEvent.aspx?EventID=105.
24. Zenenberg R, Carluccio A, Merlin M. Hyponatremia: evaluation, management. Hosp Pract 38: 89-96, 2010.